Sleep Apnoea and Excessive Daytime Sleepiness

Sleep apnoea can cause excessive daytime sleepiness, and it is one of the most clinically recognised reasons adults struggle to stay awake during the day. Obstructive sleep apnoea (OSA) repeatedly interrupts breathing during the night, fragmenting sleep so severely that even a full night in bed leaves a person feeling unrefreshed. The resulting chronic sleep deprivation affects concentration, mood, and safety, particularly when driving. This article explains why OSA causes such profound fatigue, how it is diagnosed and treated on the NHS, and when to seek medical advice.

Can sleep apnoea really cause excessive daytime sleepiness?

Yes, sleep apnoea is a leading cause of excessive daytime sleepiness, recognised by NICE guideline NG202. Repeated nocturnal breathing pauses fragment sleep, causing chronic deprivation even after a full night in bed.

Yes, sleep apnoea is one of the most common and clinically recognised causes of excessive daytime sleepiness in adults. The condition causes repeated pauses in breathing during sleep, each lasting from a few seconds to over a minute, and these interruptions fragment sleep so severely that even someone who spends eight hours in bed may wake feeling completely unrefreshed. The most prevalent form, obstructive sleep apnoea (OSA), also referred to in UK clinical guidance as obstructive sleep apnoea/hypopnoea syndrome (OSAHS), occurs when the muscles of the upper airway relax and partially or fully block the airway, causing oxygen levels to drop and the brain to briefly rouse the sleeper to restore normal breathing.

The link between OSAHS and daytime sleepiness is well established in clinical literature and is recognised by NICE guideline NG202, which identifies excessive daytime sleepiness as a cardinal symptom of the condition.^[1][2] Many people with OSA are unaware of the nocturnal arousals because they do not reach full consciousness, yet the cumulative effect of dozens or even hundreds of such events each night produces a state of chronic sleep deprivation. This manifests as difficulty concentrating, irritability, low mood, and an overwhelming urge to sleep during ordinary daytime activities such as reading, watching television, or driving.

It is important to note that not everyone with OSA experiences the same degree of daytime sleepiness. Factors including the severity of the apnoea, individual sleep architecture, age, and coexisting conditions such as depression or anaemia can all influence how fatigued a person feels. Daytime sleepiness should therefore always be assessed in the context of a full clinical history rather than attributed to a single cause without investigation.

Why does disrupted sleep leave you exhausted during the day?

Disrupted sleep prevents completion of restorative deep and REM sleep cycles, leaving the nervous system under-recovered. Intermittent hypoxia from apnoeic episodes also triggers inflammation that independently contributes to fatigue.

Disrupted sleep causes excessive daytime sleepiness because it prevents the brain and body from completing the restorative sleep cycles they require to function properly. Normal sleep progresses through several stages, including light sleep, deep slow-wave sleep, and rapid eye movement (REM) sleep, each of which serves distinct physiological functions such as memory consolidation, tissue repair, and hormonal regulation. In sleep apnoea, repeated arousals interrupt this architecture, reducing the proportion of time spent in deep and REM sleep and leaving the nervous system in a state of chronic under-recovery.

At a neurochemical level, sleep deprivation is associated with changes in sleep-promoting substances in the brain, including adenosine, which accumulates with wakefulness and is thought to be reduced during adequate sleep. When sleep is fragmented, this process is incomplete, and the resulting build-up is believed to contribute to the persistent drowsiness that characterises OSA-related fatigue. The repeated drops in blood oxygen (intermittent hypoxia) associated with apnoeic episodes are also thought to trigger inflammatory responses and oxidative stress, which may independently contribute to cognitive impairment and fatigue, though the precise mechanisms remain an active area of research.

The consequences extend beyond simple tiredness. The NHS notes that untreated OSA is associated with an increased risk of road traffic accidents, reduced workplace productivity, and impaired decision-making.^[4] People with severe OSA may fall asleep involuntarily in situations where doing so is dangerous. Understanding the physiological basis of this exhaustion helps explain why treating the underlying sleep disorder, rather than simply managing daytime symptoms, is the appropriate clinical priority.

How do doctors in the UK diagnose sleep apnoea and daytime fatigue?

UK diagnosis begins with a GP assessment using the Epworth Sleepiness Scale, followed by referral for a home or hospital sleep study measuring oxygen saturation and airflow. NICE NG202 provides the framework for investigation and referral.

In the UK, diagnosis of sleep apnoea typically begins with a GP assessment, during which the doctor will take a detailed sleep history, ask about snoring, witnessed apnoeas, and daytime sleepiness, and may use validated questionnaires such as the Epworth Sleepiness Scale (ESS) to quantify the degree of daytime impairment. A score of 11 or above on the ESS is generally considered indicative of excessive daytime sleepiness warranting further investigation, though clinical judgement remains central to the assessment.^[13]

NICE guideline NG202 supports referral to a specialist sleep service or respiratory clinic for patients in whom OSAHS is suspected.^[1][2] The standard diagnostic investigation is a sleep study, which may be conducted at home using a portable monitoring device or in a hospital sleep laboratory. Home sleep studies typically measure airflow, oxygen saturation, chest movement, and heart rate overnight. In UK practice, severity is commonly assessed using the 4% oxygen desaturation index (ODI), which counts the number of times per hour that blood oxygen falls by 4% or more, alongside symptom burden and clinical context.^[12][3] The Apnoea-Hypopnoea Index (AHI) may also be reported. Thresholds and classification may vary between local sleep services, and NICE NG202 and BTS/ARTP guidance provide the relevant UK framework.

Where daytime sleepiness has other potential causes, such as narcolepsy, restless legs syndrome, or mood disorders, additional investigations may be arranged. In some cases, specialist tests such as the Multiple Sleep Latency Test (MSLT) may be needed to confirm a diagnosis of narcolepsy, typically after OSA has been excluded or treated.^[5] Blood tests to exclude anaemia, thyroid dysfunction, or diabetes are commonly requested. A thorough diagnostic process is important because the management of daytime sleepiness differs substantially depending on its underlying cause, and treating OSA in someone whose fatigue has a different aetiology will not produce the expected benefit.

What treatments are available on the NHS for sleep apnoea?

CPAP therapy is the NHS first-line treatment for moderate to severe OSA, proven to reduce daytime sleepiness and improve quality of life. Mandibular advancement devices and lifestyle changes are options for mild OSA or CPAP-intolerant patients.

The primary NHS treatment for moderate to severe obstructive sleep apnoea is continuous positive airway pressure (CPAP) therapy, which delivers a steady stream of pressurised air through a mask worn during sleep to keep the upper airway open and prevent apnoeic episodes. NICE guideline NG202 recommends CPAP as the first-line treatment for adults with moderate or severe OSAHS.^[1][2] Evidence consistently shows that CPAP reduces daytime sleepiness, improves quality of life, and lowers blood pressure when used consistently.^[7][8] Whether CPAP reduces the risk of major cardiovascular events such as heart attack or stroke remains less certain, and the evidence from randomised controlled trials has been mixed; patients should discuss their individual risk profile with their clinician.^[9][10] CPAP devices are provided and maintained by NHS sleep services, and patients receive ongoing support to optimise mask fit and adherence, though local pathway arrangements may vary.

For people with mild OSA, or those who cannot tolerate CPAP, alternative options include:

• Mandibular advancement devices (MADs): Custom-made, titratable oral appliances fitted by a dental specialist that reposition the lower jaw to keep the airway open during sleep. NICE NG202 recommends these custom-made devices for mild to moderate OSAHS and for patients who decline or cannot use CPAP.^[1][2] Over-the-counter mouthguards are not equivalent and are not recommended as a substitute.

• Lifestyle modifications: Weight loss, reducing alcohol consumption, avoiding sedatives, and sleeping on one's side can meaningfully reduce the severity of OSA in some individuals.

• Positional therapy: Devices or techniques that discourage sleeping in the supine position, which worsens airway collapse in many patients, and which may be considered in selected cases per specialist guidance.

• Surgery: Procedures such as tonsillectomy or uvulopalatopharyngoplasty may be considered in selected cases, particularly where a structural cause is identified and assessed in a specialist centre, though surgical outcomes are variable.

For patients exploring weight management as part of a broader approach to OSA, a clinician-led assessment is the appropriate starting point. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support; any prescription treatment would only be provided where clinically appropriate following a consultation. Addressing daytime sleepiness effectively usually requires treating the sleep disorder directly alongside any contributing factors.

When should you see a GP about daytime sleepiness and poor sleep?

See a GP promptly if daytime sleepiness is persistent, affects driving safety, or is accompanied by loud snoring, witnessed breathing pauses, or morning headaches. Stop driving immediately if sleepiness impairs your ability to drive safely.

You should see a GP about daytime sleepiness if it is persistent, affects your ability to work or drive safely, or is accompanied by symptoms that suggest an underlying medical cause such as loud snoring, witnessed pauses in breathing, waking with a choking sensation, or morning headaches. These features are characteristic of sleep apnoea and warrant prompt clinical assessment. Falling asleep involuntarily during the day, particularly in situations requiring attention such as driving or operating machinery, is a patient safety concern and should be discussed with a doctor without delay.

Other symptoms that should prompt a GP appointment include:

• Daytime sleepiness that does not improve despite what appears to be adequate sleep duration

• Waking unrefreshed most mornings over a period of several weeks

• Cognitive difficulties such as poor concentration, memory lapses, or difficulty completing routine tasks

• Low mood or irritability that may be related to chronic sleep disruption

• A bed partner reporting loud snoring, gasping, or breathing pauses during the night

If daytime sleepiness is affecting your ability to drive safely, you should stop driving immediately and seek urgent medical review. Under DVLA rules, you are required to notify the DVLA when you are diagnosed with OSAHS accompanied by excessive daytime sleepiness; your GP can advise on this process and on when it is safe to resume driving.^[6] The DVLA publishes guidance on assessing fitness to drive for sleep apnoea at gov.uk/guidance/sleep-apnoea-and-driving.

For urgent concerns that arise outside of GP hours, NHS 111 can provide advice. Symptoms such as chest pain, severe breathlessness, or sudden neurological changes require immediate assessment via 999 or attendance at an accident and emergency department. Suspected side effects from any medicine used in the management of sleep-related conditions can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions